HuagongsheHuagongshe Chemistry Print Report · For research reference only
(4S,5R)-2-(6-tert-butyl-4-ethoxy-pyridin-3-yl)-4,5-bis-(4-chloro-phenyl)-4,5-dimethyl-4,5-dihydro-imidazole-1-carbonyl chloride → HCID 57669933, compound
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | (4S,5R)-2-(6-tert-butyl-4-ethoxy-pyridin-3-yl)-4,5-bis-(4-chloro-phenyl)-4,5-dimethyl-4,5-dihydro-imidazole-1-carbonyl chloride | HCID 57669958 | — |
| Reactant | HCID 68933008 | HCID 68933008 | — |
| Product | HCID 57669933 | HCID 57669933 | — |
Reaction Steps
In a manner analogous to the method described in examples 8, (4S,5R)-2-(6-tert-butyl-4-ethoxy-pyridin-3-yl)-4,5-bis-(4-chloro-phenyl)-4,5-dimethyl-4,5-dihydro-imidazole-1-carbonyl chloride (example 51) was coupled with (2R,3R,4S)-2-aminomethyl-1-(2-hydroxy-ethyl)-pyrrolidine-3,4-diol (AFID Therapeutics) to give the title compound. HR-MS (ES, m/z) calculated for C36H46Cl2N5O5 [(M+H)+] 698.2871, observed 698.2873.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US08513239B2 |
| Source dataset | uspto-grants-2013_08 |
| ORD ID | ord-6889a8c7cdad4ef69977aec87c87ae71 |
| Source note | uspto-grants-2013_08 |